Randomized Pragmatic Clinical Trial in a Community-Based Setting Comparing STIOLTO® RESPIMAT® vs. ICS-LABA Plus LAMA in Patients With COPD
Phase of Trial: Phase IV
Latest Information Update: 11 Jan 2019
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary) ; Budesonide/formoterol/glycopyrrolate
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms AIRWISE
- Sponsors Boehringer Ingelheim
- 15 Oct 2018 Planned End Date changed from 23 Jun 2020 to 23 Feb 2021.
- 15 Oct 2018 Planned primary completion date changed from 23 Jun 2020 to 23 Feb 2021.
- 23 Jan 2018 Planned End Date changed from 23 Jan 2020 to 23 Jun 2020.